Feedback Share Discussion Threads

[digger2779] 19/6/2023 08:39

Have the vets and their horses kicked us into touch? Getting through cash at a rate of knots too!!

[yump] 19/6/2023 06:59

Trading updates don’t contain orders you tiresome little midge.

[ydderf] 19/6/2023 06:50

No orders then.....

[ducatiman] 19/6/2023 06:19

More blah, blah, blah.

[ducatiman] 13/6/2023 06:29

Oakley’s dreams V reality!

[lr2] 12/6/2023 16:38

Bringing the Hewitt review’s ideals to life.

Dr Tom Oakley, Feedback Medical’s CEO, looks at the next steps following the Hewitt review ahead of this week’s NHS ConfedExpo conference.

[ydderf] 11/6/2023 09:41

"IB Nimble, the handheld app which connects medical specialists in a secure environment and allows them to establish optimal treatment plans for their patients without having to physically meet, enabling for example a virtual 'tumour board'. IB Nimble is adaptable to any disease group. The Company has now secured its first commercial contract to install an operating network for clinical use of the app in a new disease area. Interest from other potential users is being stimulated by this initial installation and we are hopeful that further contracts will ensue in due course" From the IQAI annual report a few weeks ago.

"IB Nimble" (Imaging Biometrics) is owned by IQAI, which has a Standard listing, market.The main activity of IQAI is AI applied to medical diagnostics and other projects - dyor, however if comparing the market cap of IQAI with Feedback, the man on the Clapham Omnibus might might struggle to explain the apparent anomaly...

[lr2] 08/6/2023 14:57

Some reading to combat the loneliness.

Estimated Value £975,800,000 Excluding VAT.

[ydderf] 30/5/2023 08:49

It's an ego trip - nothing is going to change while shareholders reward for failure. Years of acceptance of the status quo is not going to change now. Where's the catalyst?

[ducatiman] 29/5/2023 17:41

So based on the website this is the “team”.

Dr. Tom Oakley, ceo.
Nick Mayhew, chief marketing and sales manager
Stephen McAteer, chief operating officer.
Mike Hayball, chief technical officer.
Dr. Stephen Brown, chief regulatory and compliance officer
Anesh Patel, chief financial officer.
Sarah Bricknall, commercial advisor.
Antoine Saillant, product manager.
Carrie Goldsworthy, marketing and commercial lead.
Tara-Jane Southwell, head of tech support and deployment.
Liz Theakstone, customer success manager.
Sharon Donald, sales manager.

That’s a big payroll for virtually zero customers. I believe a cull is in order starting from the top.

Customer success manager, sales manager! I rest my case.

[lr2] 27/5/2023 15:32

"He has something akin to tenure".

Bit like you then Trev.

[ydderf] 27/5/2023 15:19

TO´s been in office for as long as a UK government, but you can get rid of a failing government and PM. Shareholders have probably paid him close to a million pounds during his time in office. President for life? - why not, nobody is going to remove him now that there are no key shareholdings. He has something akin to tenure

[ducatiman] 26/5/2023 10:17

Can’t argue with you fybberF. He’s full of sh1te, just hoping that behind our Walter CEO, there is potential and the substantial on market buying by the Professor indicates that.

[ydderf] 26/5/2023 10:07

Three years ago

Tom Oakley, CEO of Feedback plc, said:
"Papworth has been a longstanding customer of Feedback and we are delighted that they recognise the value of Bleepa (R) as part of this renewal. Enabling critical review at the push of a button, Bleepa (R) has the functionality to bring significant efficiencies and deliver real time-saving potential for its clinicians. The launch of Bleepa at Papworth is further evidence of the changing needs of frontline clinicians around their interaction with medical imaging and with colleagues, something that we are uniquely positioned to enable. We will now look to continue the spread of Bleepa to other opportunities across the healthcare setting."
Bleepa(R) provides instant and remote access to clinical grade medical images through a zero footprint application. The majority of patient cases require medical imaging which can be seamlessly shared to the entire clinical team through Bleepa (R) . Cases can be discussed through its secure instant messaging and image annotation, allowing comments and treatment decisions to be communicated instantly between team members. Bleepa (R) can be accessed from any internet connected device including phones, tablets, laptops and desktops; clinicians can use their own devices and therefore no additional hardware is required.

[ydderf] 26/5/2023 10:06

Four years ago

Dr Tom Oakley, CEO of Feedback, commented:
"An exciting opportunity has arisen from the first phase of our strategic review. We believe that Cadran's innovative features, such as the ability to view clinical grade medical images flexibly on mobile and personal devices, allow it to be repositioned to meet the needs of an emerging medical communications market, particularly in medical imaging.
"There is huge potential to improve the efficiencies and lives of our doctors and patients alike, through more flexible, secure and accurate tools utilising the highest standards in global mobile communications. We are now working swiftly to develop this new offering and make it available for the many clinicians eager to use it, both within the NHS and internationally."
Cadran is Feedback's established Picture Archiving and Communications System (PACS) which facilitates the review of medical imaging studies by clinicians. It is a progressive and rigorously tested Class 1 medical device with a longstanding legacy of service at NHS institutions, such as the Royal Papworth Hospital. However, it is currently positioned in a competitive market that shows little opportunity for future growth.

[ydderf] 26/5/2023 10:03

Two years ago TO said;

The Company remains focused on increasing revenue generating opportunities and addressing a wide range of markets both domestically and internationally for Bleepa. While it continues to be a core target, management is excited by the increasing number of prospects and leads both in and outside of the NHS and has a strong pipeline of opportunity. There is a growing requirement for remote solutions and Bleepa leads at the forefront of the market. Management expects to benefit from increasing demand for its solutions enabling it to grow repeat revenues and benefit from increasing visibility afforded by its Software as a Service model.

[ydderf] 26/5/2023 09:56

..and so the years pass by, the dialogue between the old boys never ending but endlessly in denial about what is not happening here...where is the profit and sales meat as the placing machine gets warmed up yet again? How many millions of pounds and how many years now has TO had to do something real? Lr2 and co, will you ever bail or does the company have to be closed down for the dream to finally die?

[lr2] 25/5/2023 12:38

No. Not a sign of him over the last month. Perhaps, he's in India.

[ducatiman] 25/5/2023 12:01

Anyone spotted TO recently?

[paddygangster] 22/5/2023 13:11

When is the next placing

[digger2779] 22/5/2023 12:18

A little bit of buying interest.